Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

METHOD FOR TREATMENT OF KAPOSI'S SARCOMA (KS) BY ANTISENSE OLIGONUCLEOTIDES

  • Read more about METHOD FOR TREATMENT OF KAPOSI'S SARCOMA (KS) BY ANTISENSE OLIGONUCLEOTIDES
US Application 08/072,575
Filed on 1993-06-04

Human Cell Adhesion Protein AAMP-1 And Uses Thereof

  • Read more about Human Cell Adhesion Protein AAMP-1 And Uses Thereof
US Patent 6,274,134
Filed on 1993-06-25

PEPTIDE INHIBITORS OF PROTEIN TYROSINE KINASE - SH2 INTERACTIONS

  • Read more about PEPTIDE INHIBITORS OF PROTEIN TYROSINE KINASE - SH2 INTERACTIONS
US Application 08/072,946
Filed on 1993-06-08

RECOMBINANT DISULFIDE-STABILIZED POLYPEPTIDE FRAGMENTS HAVING BINDING SPECIFICITY

  • Read more about RECOMBINANT DISULFIDE-STABILIZED POLYPEPTIDE FRAGMENTS HAVING BINDING SPECIFICITY
US Patent 5,747,654
Filed on 1993-06-14

INHIBITION OF SMALL CELL LUNG CANCER CELL GROWTH IN VIVO USING MONOCLONAL ANTIBODY

  • Read more about INHIBITION OF SMALL CELL LUNG CANCER CELL GROWTH IN VIVO USING MONOCLONAL ANTIBODY
US Patent 5,460,801
Filed on 1993-04-15

MOUSE MONOCLONAL ANTIBODIES SPECIFIC FOR NORMAL PRIMATE TISSUE, MALIGNANT HUMAN CULTURED CELL LINES OF HUMAN TUMORS

  • Read more about MOUSE MONOCLONAL ANTIBODIES SPECIFIC FOR NORMAL PRIMATE TISSUE, MALIGNANT HUMAN CULTURED CELL LINES OF HUMAN TUMORS
US Application 08/051,133
Filed on 1993-04-22

NEW PROCEDURE TO BLOCK THE REPLICATION OF REVERSE TRANSCRIPTASE DEPEN- DENT VIRUSES BY THE USE OF INHIBITORS OF DEOXYNUCLEOTIDES SYNTHESIS

  • Read more about NEW PROCEDURE TO BLOCK THE REPLICATION OF REVERSE TRANSCRIPTASE DEPEN- DENT VIRUSES BY THE USE OF INHIBITORS OF DEOXYNUCLEOTIDES SYNTHESIS
US Application 08/065,814
Filed on 1993-05-21

IMMORTALIZED HUMAN CELL LINES CONTAINING EXOGENOUS CYTOCHROME P450 GENES

  • Read more about IMMORTALIZED HUMAN CELL LINES CONTAINING EXOGENOUS CYTOCHROME P450 GENES
US Patent 5,506,131
Filed on 1993-05-19

METHOD FOR TREATING ACNE

  • Read more about METHOD FOR TREATING ACNE
US Patent 5,698,593
Filed on 1993-04-15

VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE

  • Read more about VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE
US Patent 5,654,138
Filed on 1993-05-14

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1601
  • Page 1602
  • Page 1603
  • Page 1604
  • Page 1605
  • Page 1606
  • Page 1607
  • Page 1608
  • Page 1609
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health